FDA Inspection
Livzon Group (Ningxia) Pharmaceutical Co., Ltd.Livzon Group (Ningxia) Pharmaceutical Co., Ltd. – FDA Inspection, Jan 13, 2017
Record Details
This FDA Inspection record concerns Livzon Group (Ningxia) Pharmaceutical Co., Ltd., with an inspection on January 13, 2017, issued by the Center for Veterinary Medicine, covering veterinary.
- Inspection Date
- January 13, 2017
- Product Type
- Veterinary
- Person
View Company Profile
ID · b3c7fe6a-532f-4d1a-9777-125f9bdba24d
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 998978
- FDA center
- Animal Drugs & Feeds
- Project area
- Pre-Approval Eval. of Animal Drugs and Food Additives
- Outcome
- Form 483 issued
Other FDA inspections of Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2025 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| December 6, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 19, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
- FDA Inspection 1286526 - 2025-09-05
- FDA Inspection 1115730 - 2019-12-06
- FDA Inspection 1070291 - 2018-10-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.